INS and Alzheimer disease: Biomarkers of neuroinflammation, metabolic-regulating hormones, insulin signaling, energy sensors, and neuropeptide levels were assessed in an attempt to gain insight into how energy balance is disrupted, contributing to development of AD pathology.